Drug Database
Back to search

Finland· FI-REL-REL1167

Clinoril

A sulindac product containing sulindac, registered in Finland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 6 of our 19 countries.

ATC M01AB02

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedClinorilATCM01AB02REGISTER NO.FI-REL-REL1167PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sulindacAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sulindac is registered in 6 of 19 countries.

Countries holding a registration under ATC M01AB02 (sulindac), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose
Search sulindac products by name

Sulindac · ATC M01AB02

6 / 19 countries

  • Canada
  • Finlandprice
  • Franceprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sulindac costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sulindac · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • FR France$0.48
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Sulindac
Manufacturer
Merck Sharp & Dohme B.V.
Country
Finland (FI)
ATC code
M01AB02
ATC class
Sulindac
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

249 interactions on record for sulindac.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sulindac against other medicinesHow interaction checks work

Sulindac · interactions on record

249 records

  • 59 severe
  • 142 moderate
  • 5 minor
  • 43 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sulindac in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulindac products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • France · Arthrocine
  • United Kingdom (Northern Ireland) · Sulindac Chemidex Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4a7fd675-e1f3-4069-9346-ad93917d79c8
GET /v1/drugs/4a7fd675-e1f3-4069-9346-ad93917d79c8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.4",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "g",
  "strength": "100 mg",
  "atc_label": "sulindaakki",
  "ma_number": "7463",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1167",
  "authorised_at": "1977-08-31"
}
API referenceMCP serverPlans

See everything about sulindac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console